Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway.

La Paglia L, Listì A, Caruso S, Amodeo V, Passiglia F, Bazan V, Fanale D.

PPAR Res. 2017;2017:8187235. doi: 10.1155/2017/8187235. Epub 2017 Jan 15. Review.

2.

The Glucocorticoid Receptor Regulates the ANGPTL4 Gene in a CTCF-Mediated Chromatin Context in Human Hepatic Cells.

Nakamoto M, Ishihara K, Watanabe T, Hirosue A, Hino S, Shinohara M, Nakayama H, Nakao M.

PLoS One. 2017 Jan 5;12(1):e0169225. doi: 10.1371/journal.pone.0169225. eCollection 2017.

3.

Fasting and Feeding Signals Control the Oscillatory Expression of Angptl8 to Modulate Lipid Metabolism.

Dang F, Wu R, Wang P, Wu Y, Azam MS, Xu Q, Chen Y, Liu Y.

Sci Rep. 2016 Nov 15;6:36926. doi: 10.1038/srep36926.

4.

Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.

Bluemel S, Williams B, Knight R, Schnabl B.

Am J Physiol Gastrointest Liver Physiol. 2016 Dec 1;311(6):G1018-G1036. doi: 10.1152/ajpgi.00245.2016. Epub 2016 Sep 29. Review.

PMID:
27686615
5.

ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression.

Aryal B, Rotllan N, Araldi E, Ramírez CM, He S, Chousterman BG, Fenn AM, Wanschel A, Madrigal-Matute J, Warrier N, Martín-Ventura JL, Swirski FK, Suárez Y, Fernández-Hernando C.

Nat Commun. 2016 Jul 27;7:12313. doi: 10.1038/ncomms12313.

6.

Nutrigenomics and its Impact on Life Style Associated Metabolic Diseases.

Rana S, Kumar S, Rathore N, Padwad Y, Bhushana S.

Curr Genomics. 2016 Jun;17(3):261-78. doi: 10.2174/1389202917666160202220422.

7.

The Intestinal Microbiota in Metabolic Disease.

Woting A, Blaut M.

Nutrients. 2016 Apr 6;8(4):202. doi: 10.3390/nu8040202. Review.

8.

The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking.

Zhang R.

Open Biol. 2016 Apr;6(4):150272. doi: 10.1098/rsob.150272. Review.

9.

Implication of hepatokines in metabolic disorders and cardiovascular diseases.

Jung TW, Yoo HJ, Choi KM.

BBA Clin. 2016 Mar 5;5:108-13. doi: 10.1016/j.bbacli.2016.03.002. eCollection 2016 Jun. Review.

10.

Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism.

Minicocci I, Tikka A, Poggiogalle E, Metso J, Montali A, Ceci F, Labbadia G, Fontana M, Di Costanzo A, Maranghi M, Rosano A, Ehnholm C, Donini LM, Jauhiainen M, Arca M.

J Lipid Res. 2016 Jun;57(6):1097-107. doi: 10.1194/jlr.P066183. Epub 2016 Apr 3.

PMID:
27040449
11.

Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes.

Dijk W, Beigneux AP, Larsson M, Bensadoun A, Young SG, Kersten S.

J Lipid Res. 2016 Sep;57(9):1670-83. doi: 10.1194/jlr.M067363. Epub 2016 Mar 31. Erratum in: J Lipid Res. 2016 Oct;57(10 ):1949-1950.

PMID:
27034464
12.

Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders.

Yoo JY, Kim SS.

Nutrients. 2016 Mar 18;8(3):173. doi: 10.3390/nu8030173. Review.

13.
14.

Angptl4 links α-cell proliferation following glucagon receptor inhibition with adipose tissue triglyceride metabolism.

Ben-Zvi D, Barrandon O, Hadley S, Blum B, Peterson QP, Melton DA.

Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):15498-503. doi: 10.1073/pnas.1513872112. Epub 2015 Nov 30.

15.

ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure.

Dijk W, Heine M, Vergnes L, Boon MR, Schaart G, Hesselink MK, Reue K, van Marken Lichtenbelt WD, Olivecrona G, Rensen PC, Heeren J, Kersten S.

Elife. 2015 Oct 17;4. pii: e08428. doi: 10.7554/eLife.08428.

16.

Lactobacillus rhamnosus CNCMI-4317 Modulates Fiaf/Angptl4 in Intestinal Epithelial Cells and Circulating Level in Mice.

Jacouton E, Mach N, Cadiou J, Lapaque N, Clément K, Doré J, van Hylckama Vlieg JE, Smokvina T, Blottière HM.

PLoS One. 2015 Oct 6;10(10):e0138880. doi: 10.1371/journal.pone.0138880. eCollection 2015.

17.

Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease.

Li JS, Chen X, Peng L, Wei SY, Zhao SL, Diao TT, He YX, Liu F, Wei QJ, Zhang QF, Li B.

PLoS One. 2015 Sep 9;10(9):e0137049. doi: 10.1371/journal.pone.0137049. eCollection 2015.

18.

Hepatic ANGPTL3 regulates adipose tissue energy homeostasis.

Wang Y, McNutt MC, Banfi S, Levin MG, Holland WL, Gusarova V, Gromada J, Cohen JC, Hobbs HH.

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11630-5. doi: 10.1073/pnas.1515374112. Epub 2015 Aug 24.

19.

Angptl4 is upregulated under inflammatory conditions in the bone marrow of mice, expands myeloid progenitors, and accelerates reconstitution of platelets after myelosuppressive therapy.

Schumacher A, Denecke B, Braunschweig T, Stahlschmidt J, Ziegler S, Brandenburg LO, Stope MB, Martincuks A, Vogt M, Görtz D, Camporeale A, Poli V, Müller-Newen G, Brümmendorf TH, Ziegler P.

J Hematol Oncol. 2015 Jun 9;8:64. doi: 10.1186/s13045-015-0152-2.

20.

Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.

Chi X, Shetty SK, Shows HW, Hjelmaas AJ, Malcolm EK, Davies BS.

J Biol Chem. 2015 May 8;290(19):11865-77. doi: 10.1074/jbc.M114.623769. Epub 2015 Mar 25.

Supplemental Content

Support Center